BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22787226)

  • 1. 5'-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation.
    Lin L; Liu Q; Berube N; Detmer S; Zhou Y
    J Virol; 2012 Oct; 86(19):10359-69. PubMed ID: 22787226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDX5/METTL3-METTL14/YTHDF2 Axis Regulates Replication of Influenza A Virus.
    Zhao L; Zhao Y; Liu Q; Huang J; Lu Y; Ping J
    Microbiol Spectr; 2022 Jun; 10(3):e0109822. PubMed ID: 35583334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of a novel self-assembled immunostimulatory siRNA combining apoptosis promotion with RIG-I activation in gliomas.
    Chen J; Liu Z; Fang H; Su Q; Fan Y; Song L; He S
    J Transl Med; 2024 Apr; 22(1):395. PubMed ID: 38685028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity.
    Chiang JJ; Sparrer KMJ; van Gent M; Lässig C; Huang T; Osterrieder N; Hopfner KP; Gack MU
    Nat Immunol; 2018 Jan; 19(1):53-62. PubMed ID: 29180807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of mda-5 Inhibition by paramyxovirus V proteins.
    Childs KS; Andrejeva J; Randall RE; Goodbourn S
    J Virol; 2009 Feb; 83(3):1465-73. PubMed ID: 19019954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Identification and Function of Linc01615 on Influenza Virus Infection and Antiviral Response.
    Yin G; Hu J; Huang X; Cai Y; Gao Z; Guo X; Feng X
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of immune-stimulating bispecific RNA, inducing apoptosis and anti-tumor immunity in cancer cells.
    Rady T; Erb S; Deddouche-Grass S; Morales R; Chaubet G; Cianférani S; Basse N; Wagner A
    iScience; 2024 Mar; 27(3):109068. PubMed ID: 38380254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular targets for influenza drugs.
    Min JY; Subbarao K
    Nat Biotechnol; 2010 Mar; 28(3):239-40. PubMed ID: 20212486
    [No Abstract]   [Full Text] [Related]  

  • 9. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
    Chiang C; Beljanski V; Yin K; Olagnier D; Ben Yebdri F; Steel C; Goulet ML; DeFilippis VR; Streblow DN; Haddad EK; Trautmann L; Ross T; Lin R; Hiscott J
    J Virol; 2015 Aug; 89(15):8011-25. PubMed ID: 26018150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIG-I agonist SLR10 promotes macrophage M1 polarization during influenza virus infection.
    Wu W; Zhang W; Alexandar JS; Booth JL; Miller CA; Xu C; Metcalf JP
    Front Immunol; 2023; 14():1177624. PubMed ID: 37475869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection.
    Schwab LSU; Farrukee R; Eléouët JF; Rameix-Welti MA; Londrigan SL; Brooks AG; Hurt AC; Coch C; Zillinger T; Hartmann G; Reading PC
    J Infect Dis; 2022 Dec; 226(12):2079-2088. PubMed ID: 35861054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome Analysis of Retinoic Acid-Inducible Gene I Overexpression Reveals the Potential Genes for Autophagy-Related Negative Regulation.
    Ye S; Tan C; Yang X; Wang J; Li Q; Xu L; Wang Z; Mao J; Wang J; Cheng K; Chen A; Zhou P; Li S
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections.
    Seo SU; Seong BL
    Front Immunol; 2022; 13():877845. PubMed ID: 35651619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection.
    Marx S; Kümmerer BM; Grützner C; Kato H; Schlee M; Renn M; Bartok E; Hartmann G
    Mol Ther Nucleic Acids; 2022 Mar; 27():1225-1234. PubMed ID: 35186439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Activity of Canine RIG-I against Canine Influenza Virus and Interactions between Canine RIG-I and CIV.
    Wang Z; Ye S; Yao C; Wang J; Mao J; Xu L; Liu Y; Fu C; Lu G; Li S
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine Reproductive and Respiratory Syndrome Virus: Immune Escape and Application of Reverse Genetics in Attenuated Live Vaccine Development.
    Wang H; Xu Y; Feng W
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34068505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Sensing of Influenza A Virus.
    Malik G; Zhou Y
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32674269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dual-Functioning 5'-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1.
    Singh N; Ranjan P; Cao W; Patel J; Gangappa S; Davidson BA; Sullivan JM; Prasad PN; Knight PR; Sambhara S
    Mol Ther Nucleic Acids; 2020 Mar; 19():1413-1422. PubMed ID: 32160710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transportan-derived cell-penetrating peptide delivers siRNA to inhibit replication of influenza virus in vivo.
    Zhang C; Ren W; Liu Q; Tan Z; Li J; Tong C
    Drug Des Devel Ther; 2019; 13():1059-1068. PubMed ID: 31040643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Downregulation of MicroRNA hsa-miR-340-5p in IAV-Infected A549 Cells Suppresses Viral Replication by Targeting RIG-I and OAS2.
    Zhao L; Zhang X; Wu Z; Huang K; Sun X; Chen H; Jin M
    Mol Ther Nucleic Acids; 2019 Mar; 14():509-519. PubMed ID: 30753994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.